Award Advances Critical Work That Started in 2018. Beckman Coulter Life Sciences, a global leader in laboratory automation ...

SAN FRANCISCO - Nurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company specializing in targeted protein modulation drugs, announced today the appointment of John Northcott as its new ...

Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia ...

A new ICMR study reveals one in nine Indians is at risk of cancer. Lung and breast cancers are the most common, with lymphoid ...

Probably the only reasonable response to such a speech.

Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes ...

New data suggest venetoclax may offset the negative prognostic impact of short telomeres in patients with chronic lymphocytic ...

In an interview, Paolo Ghia, MD, PhD, discussed updated data from the phase 2 CAPTIVATE trial of ibrutinib and venetoclax in ...

The following is a summary of “Critically ill adult patients with acute leukemia: a systematic review and meta-analysis,” published in the January 2025 issue of Critical Care by Chean et al. Researche ...

Georgia Mills, M.B.B.S., from Northern Beaches Hospital in Sydney, and colleagues developed a position statement on the diagnosis and management of acute leukemia and aggressive lymphomas in pregnancy ...

In an interview, Andrew Kuykendall, MD, discussed fedratinib’s potential as an effective option for patients with ...

The ringing of the bell that signified the long-awaited end to the toddler’s cancer treatment was music to her parent’ ears.